|Dan Ferry||IR, LifeSci Advisors|
|Fahar Merchant||President & CEO|
|David Martin||Bloom Burton|
|Swayampakula Ramakanth||H.C. Wainwright|
|Andre Uddin||Mackie Research Capital|
|Shubhendu Roy||Brookline Capital Markets|
|David Bautz||Zacks Small-Cap Research|
Hello, and welcome to the Medicenna Therapeutics Fiscal Year-End Earnings Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. I would now like to turn the call over to Dan Ferry of LifeSci Advisors.